Legend Biotech's Q1 2025 Results Highlight Carvykti Sales Growth
Company

Legend Biotech’s Q1 2025 Results Highlight Carvykti Sales Growth

Sanyou Biopharmaceuticals and TransReco Bio Partner to Advance Novel Drug Formulations
CompanyDeals

Sanyou Biopharmaceuticals and TransReco Biotechnology Partner to Advance Novel Drug Formulations

Novo Nordisk Partners with PingAn Good Doctor to Promote Scientific Weight Loss in China
CompanyDeals

Novo Nordisk Partners with PingAn Good Doctor to Promote Scientific Weight Loss in China

BRL Medicine Reports Positive Results for TyU19 in Refractory SLE Trial
CompanyDrug

BRL Medicine Reports Positive Results for TyU19 in Refractory SLE Trial

InnoCare Pharma Partners with Westlake University for Innovative Drug Research
CompanyDeals

InnoCare Pharma Partners with Westlake University for Innovative Drug Research

Betta Pharmaceuticals Secures Macau Approval for Ensartinib
CompanyDrug

Betta Pharmaceuticals Secures Macau Approval for Ensartinib

OYMotion Technologies Secures RMB 100 Million in Series B++ Funding for Exoskeleton Robots
CompanyDeals

OYMotion Technologies Secures RMB 100 Million in Series B++ Funding for Exoskeleton Robots

Genentech to Invest Over $700 Million in North Carolina Drug Manufacturing Facility
CompanyDeals

Genentech to Invest Over $700 Million in North Carolina Drug Manufacturing Facility

Huadong Medicine Presents DR10624 Study Results for Obesity and Hypertriglyceridemia at EASL 2025
CompanyDrug

Huadong Medicine Presents DR10624 Study Results for Obesity and Hypertriglyceridemia at EASL 2025

Teva Announces 8% Workforce Reduction to Achieve $700 Million Cost-Saving Goal
Company

Teva Announces 8% Workforce Reduction to Achieve $700 Million Cost-Saving Goal

Formosa Pharmaceuticals Signs Licensing Deal with Laboratorios Saval for APP13007
CompanyDeals

Formosa Pharmaceuticals Signs Licensing Deal with Laboratorios Saval for APP13007

Hybio Partners with iCarbonX to Develop Triple Agonist for Metabolic Diseases
CompanyDeals

Hybio Partners with iCarbonX to Develop Triple Agonist for Metabolic Diseases